Here are the Form 4 insider transactions from Exascale Labs Holdings Inc. (XLAB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow XLAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XLAB filings page.
Exascale Labs Holdings Inc. director David Edward Card received an award of 15,000 restricted stock units on October 6, 2026. Each unit represents a contingent right to receive one share of Class A common stock upon vesting and settlement. The units vest in full on the earlier of the first anniversary of the grant date or the scheduled expiration of his director term at an annual meeting where he is not nominated for re-election, subject to his continued service through the applicable vesting date.
Exascale Labs Holdings Inc. (XLAB) director Shachar Kariv received a grant of 15,000 restricted stock units on October 6, 2026, leaving a reported direct RSU position of 15,000. Each unit represents a contingent right to one Class A common share upon vesting and settlement. The units vest in full on the earlier of the grant's first anniversary or the scheduled expiration of Kariv's director term at an annual meeting where he is not nominated for re-election, subject to continued service through the applicable vesting date.
Exascale Labs Holdings Inc. (XLAB) reported that director Jaeyoung Shin was granted 15,000 restricted stock units on October 6, 2026. The reported position after the grant was 15,000 RSUs. Each RSU is a contingent right to receive one share of Class A common stock upon vesting and settlement. The award was made under the 2026 Omnibus Equity Incentive Plan as an Initial Award under the Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of the first anniversary of the grant date or the scheduled expiration of Shin’s director term at an annual meeting where he is not nominated for re-election, subject to his continued service through the applicable vesting date.
Exascale Labs Holdings Inc. (XLAB) Chief Executive Officer Hoan Soo Lee received an award of 300,000 restricted stock units on October 6, 2026. Each RSU represents a contingent right to receive one share of Class A common stock upon vesting and settlement. The RSUs vest in three equal installments on August 27, 2027, August 27, 2028 and August 27, 2029, subject to continued employment through each date and the employment agreement’s accelerated vesting provisions. His reported position following the award was 300,000 RSUs.